R&D

OmniaMed Co., Ltd. opens up a new paradigm for the development of treatments using Nitric Oxide functionality.

Tech2

  • NO is an important signaling substance in the immune response of inflammation and tumor sites.
  • Inflammation and tumor-related diseases, NO is mostly over-expressed.
  • The effectiveness of several treatments is limited by the different actions of over-expressed NO.
  • Tech 2 eliminates NO in microenvironments to maximize therapeutic effectiveness of existing treatments